Neonatal Immunity to Bordetella pertussis Infection and Current Prevention Strategies

J Immunol Res. 2019 Feb 10:2019:7134168. doi: 10.1155/2019/7134168. eCollection 2019.

Abstract

Bordetella pertussis is the bacterial agent of whooping cough, an infectious disease that is reemerging despite high vaccine coverage. Newborn children are the most affected, not only because they are too young to be vaccinated but also due to qualitative and quantitative differences in their immune system, which makes them more susceptible to infection and severe manifestations, leading to a higher mortality rate comparing to other groups. Until recently, prevention consisted of vaccinating children in the first year of life and the herd vaccination of people directly in touch with them, but the increase in cases demands more effective strategies that can overcome the developing immune response in early life and induce protection while children are most vulnerable.

Publication types

  • Review

MeSH terms

  • Animals
  • Antibodies, Bacterial / blood
  • Bordetella pertussis / immunology*
  • Humans
  • Immunity, Herd
  • Infant, Newborn
  • Mice
  • Pertussis Vaccine / administration & dosage
  • Pertussis Vaccine / immunology
  • Vaccination
  • Whooping Cough / immunology*
  • Whooping Cough / prevention & control*

Substances

  • Antibodies, Bacterial
  • Pertussis Vaccine